Latest Court Approvals News

Aurumin Limited shareholders and optionholders have overwhelmingly approved a scheme of arrangement for Brightstar Resources to acquire 100% of Aurumin shares, setting the stage for imminent court approval and market suspension.

Warriedar Resources Limited’s shares will be suspended from trading following court approval of Capricorn Metals’ acquisition scheme, marking a significant consolidation in Western Australia’s gold mining sector.

Aurumin Limited shareholders and optionholders convened on 14 November 2025 to vote on a scheme of arrangement for Brightstar Resources to acquire 100% of Aurumin, with strong proxy support signaling broad approval ahead of final court sanction.

Infomedia Limited has secured Foreign Investment Review Board approval for its proposed acquisition by TPG Capital-backed McQueen BidCo, marking a key regulatory milestone. The Infomedia Board continues to recommend shareholder support ahead of upcoming votes.

Capricorn Metals Ltd has officially completed its acquisition of Warriedar Resources Limited through a court-approved scheme of arrangement, marking a significant consolidation in the gold mining sector.

The Supreme Court of Western Australia has approved the share and option schemes for Capricorn Metals’ acquisition of Warriedar Resources, setting the stage for a significant consolidation in the gold exploration sector.

The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.

Seven West Media shareholders are preparing to vote on a scheme of arrangement for acquisition by Southern Cross Media Group, with the Seven board unanimously recommending approval. The merger promises significant cost synergies and a stronger combined media platform.

GoviEx Uranium has received the Supreme Court of British Columbia's final approval for its reverse takeover of Tombador Iron, setting the stage for completion by mid-November 2025.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a regulatory delay as the Foreign Investment Review Board extends its approval deadline, pushing the court hearing to mid-November.

Macquarie Group Limited has announced a quarterly distribution of AUD 1.5799 per security on its perpetual capital notes, reflecting a steady income stream with partial franking. The payment is scheduled for December 12, 2025.

Warriedar Resources shareholders have overwhelmingly approved a scheme of arrangement for acquisition by Capricorn Metals, clearing a key hurdle ahead of final court approval and delisting.